Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blanchet

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Journal of Morphology|April 1, 1984
Intercellular bridges in ovaries of the newborn gerbilH D McReynolds, L J Blanchet, D C Bowman, et al.
Neuroscience and Biobehavioral Reviews|July 1, 1997
Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's diseaseP J Blanchet, S M Papa, L V Metman, et al.
Neurology|July 17, 1999
Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover studyP J Blanchet, J Fang, K Hyland, et al.
Osteoarthritis and Cartilage|January 9, 2007
Osteoarthritis severity is sex dependent in a surgical mouse modelH-L Ma, T J Blanchet, D Peluso, et al.
Brain Research. Molecular Brain Research|July 1, 1996
L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeysJ J Soghomonian, S Pedneault, P J Blanchet, et al.
Clinical Neuropharmacology|June 8, 2001
Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxismG J Lavigne, J P Soucy, F Lobbezoo, et al.
Amino Acids|January 1, 1999
Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's diseaseL Verhagen Metman, P Del Dotto, P J Blanchet, et al.
Experimental Neurology|October 24, 1998
Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavengerP J Blanchet, S Konitsiotis, K Hyland, et al.
Molecular Pharmacology|November 1, 1996
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanineM Morissette, M Goulet, F Calon, et al.
Neurochemistry International|July 14, 1999
Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA contentF Calon, M Morissette, M Goulet, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Journal of Morphology|April 1, 1984
Intercellular bridges in ovaries of the newborn gerbilH D McReynolds, L J Blanchet, D C Bowman, et al.
Neuroscience and Biobehavioral Reviews|July 1, 1997
Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's diseaseP J Blanchet, S M Papa, L V Metman, et al.
Neurology|July 17, 1999
Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover studyP J Blanchet, J Fang, K Hyland, et al.
Osteoarthritis and Cartilage|January 9, 2007
Osteoarthritis severity is sex dependent in a surgical mouse modelH-L Ma, T J Blanchet, D Peluso, et al.
Brain Research. Molecular Brain Research|July 1, 1996
L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeysJ J Soghomonian, S Pedneault, P J Blanchet, et al.
Clinical Neuropharmacology|June 8, 2001
Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxismG J Lavigne, J P Soucy, F Lobbezoo, et al.
Amino Acids|January 1, 1999
Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's diseaseL Verhagen Metman, P Del Dotto, P J Blanchet, et al.
Experimental Neurology|October 24, 1998
Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavengerP J Blanchet, S Konitsiotis, K Hyland, et al.
Molecular Pharmacology|November 1, 1996
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanineM Morissette, M Goulet, F Calon, et al.
Neurochemistry International|July 14, 1999
Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA contentF Calon, M Morissette, M Goulet, et al.
Pageof 11